PT2825559T - Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativo - Google Patents
Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativoInfo
- Publication number
- PT2825559T PT2825559T PT13739281T PT13739281T PT2825559T PT 2825559 T PT2825559 T PT 2825559T PT 13739281 T PT13739281 T PT 13739281T PT 13739281 T PT13739281 T PT 13739281T PT 2825559 T PT2825559 T PT 2825559T
- Authority
- PT
- Portugal
- Prior art keywords
- bispecific antibodies
- readily isolated
- native immunoglobulin
- isolated bispecific
- immunoglobulin format
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261610141P | 2012-03-13 | 2012-03-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2825559T true PT2825559T (pt) | 2019-06-07 |
Family
ID=48803578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT13739281T PT2825559T (pt) | 2012-03-13 | 2013-03-13 | Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativo |
Country Status (9)
Country | Link |
---|---|
US (3) | US9815909B2 (pt) |
EP (2) | EP3517548A1 (pt) |
JP (3) | JP6273219B2 (pt) |
AU (2) | AU2013234039B2 (pt) |
CA (1) | CA2867020C (pt) |
DK (1) | DK2825559T3 (pt) |
ES (1) | ES2728301T3 (pt) |
PT (1) | PT2825559T (pt) |
WO (1) | WO2013136186A2 (pt) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10011858B2 (en) | 2005-03-31 | 2018-07-03 | Chugai Seiyaku Kabushiki Kaisha | Methods for producing polypeptides by regulating polypeptide association |
DK3056568T3 (da) | 2006-03-31 | 2021-11-01 | Chugai Pharmaceutical Co Ltd | Fremgangsmåder til kontrollering af antistoffers blodfarmakokinetik |
ES2654040T3 (es) | 2006-03-31 | 2018-02-12 | Chugai Seiyaku Kabushiki Kaisha | Método de modificación de anticuerpos para la purificación de anticuerpos biespecíficos |
CL2008002886A1 (es) | 2007-09-26 | 2009-12-04 | Chugai Pharmaceutical Co Ltd | Region constante de un anticuerpo humano; anticuerpo anti-receptor de interleucina-6 (il-6) y composicion farmaceutica que la comprende. |
CN106519025B (zh) | 2007-09-26 | 2021-04-23 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
US10435458B2 (en) | 2010-03-04 | 2019-10-08 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variants with reduced Fcgammar binding |
TR201802772T4 (tr) | 2010-11-17 | 2018-03-21 | Chugai Pharmaceutical Co Ltd | Kan pıhtılaşma faktörü VIII in işlevi için alternatif işleve sahip multi-spesifik antijen bağlayıcı molekül. |
AR084053A1 (es) | 2010-11-30 | 2013-04-17 | Chugai Pharmaceutical Co Ltd | Agente terapeutico que induce citotoxicidad |
AU2013322710A1 (en) | 2012-09-25 | 2015-04-16 | Glenmark Pharmaceuticals S.A. | Purification of hetero-dimeric immunoglobulins |
EP3041865A2 (en) * | 2013-09-03 | 2016-07-13 | NovImmune S.A. | Readily isolated bispecific binding molecules with native format having mutated constant regions |
BR112016006197B1 (pt) | 2013-09-27 | 2023-04-11 | Chugai Seiyaku Kabushiki Kaisha | Método para produzir um anticorpo biespecífico de polipeptídeos |
GB201411420D0 (en) * | 2014-06-26 | 2014-08-13 | Ucb Biopharma Sprl | Antibody constructs |
AR101262A1 (es) * | 2014-07-26 | 2016-12-07 | Regeneron Pharma | Plataforma de purificación para anticuerpos biespecíficos |
GB201414823D0 (en) | 2014-08-20 | 2014-10-01 | Argen X Bv | Multispecific antibodies |
EP3279216A4 (en) | 2015-04-01 | 2019-06-19 | Chugai Seiyaku Kabushiki Kaisha | PROCESS FOR PREPARING POLYPEPTIDE HETERO OLIGOMER |
EP3280444A4 (en) | 2015-04-10 | 2019-03-27 | Adimab, LLC | METHOD FOR CLEANING HETERODIMEROUS MULTISPECIFIC ANTIBODIES FROM PARENTAL HOMODIMERIC ANTIBODY TYPES |
PL3294775T3 (pl) | 2015-05-12 | 2021-12-13 | Regeneron Pharmaceuticals, Inc. | Oznaczanie czystości białka multimerycznego |
US20180201693A1 (en) | 2015-07-09 | 2018-07-19 | Genmab A/S | Bispecific and multispecific antibodies and method for isolation of such |
WO2017115773A1 (ja) | 2015-12-28 | 2017-07-06 | 中外製薬株式会社 | Fc領域含有ポリペプチドの精製を効率化するための方法 |
CN109153728A (zh) | 2016-03-21 | 2019-01-04 | 埃尔斯塔治疗公司 | 多特异性和多功能分子及其用途 |
US20200291089A1 (en) | 2017-02-16 | 2020-09-17 | Elstar Therapeutics, Inc. | Multifunctional molecules comprising a trimeric ligand and uses thereof |
WO2018212556A1 (en) * | 2017-05-16 | 2018-11-22 | Cj Healthcare Corporation | A method for purifying an antibody or an antibody fragment thereof using affinity chromatography |
WO2018222901A1 (en) | 2017-05-31 | 2018-12-06 | Elstar Therapeutics, Inc. | Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof |
WO2018224951A2 (en) * | 2017-06-05 | 2018-12-13 | Janssen Biotech, Inc. | Engineered multispecific antibodies and other multimeric proteins with asymmetrical ch2-ch3 region mutations |
WO2019035938A1 (en) | 2017-08-16 | 2019-02-21 | Elstar Therapeutics, Inc. | MULTISPECIFIC MOLECULES BINDING TO BCMA AND USES THEREOF |
MX2020004561A (es) | 2017-11-02 | 2020-08-13 | Bayer Ag | Anticuerpos biespecificos que se unen a alk-1 y bmpr-2. |
AU2018387829A1 (en) | 2017-12-22 | 2020-05-07 | Argenx Bvba | Bispecific antigen binding construct |
US20210009711A1 (en) | 2018-03-14 | 2021-01-14 | Elstar Therapeutics, Inc. | Multifunctional molecules and uses thereof |
EP3765517A1 (en) | 2018-03-14 | 2021-01-20 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to calreticulin and uses thereof |
US20210269509A1 (en) | 2018-06-22 | 2021-09-02 | Genmab A/S | Method for producing a controlled mixture of two or more different antibodies |
AU2019297451A1 (en) | 2018-07-03 | 2021-01-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
JP2024504880A (ja) | 2018-12-24 | 2024-02-02 | サノフイ | 疑似fabベースの多重特異性結合タンパク質 |
WO2020172571A1 (en) | 2019-02-21 | 2020-08-27 | Elstar Therapeutics, Inc. | Multifunctional molecules that bind to t cell related cancer cells and uses thereof |
CN114127111A (zh) | 2019-02-21 | 2022-03-01 | 马伦戈治疗公司 | 与nkp30结合的抗体分子及其用途 |
AU2020226904A1 (en) | 2019-02-21 | 2021-09-16 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
SG11202109056TA (en) | 2019-02-21 | 2021-09-29 | Marengo Therapeutics Inc | Multifunctional molecules that bind to calreticulin and uses thereof |
SG11202109033XA (en) | 2019-02-21 | 2021-09-29 | Marengo Therapeutics Inc | Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disorders |
WO2021138407A2 (en) | 2020-01-03 | 2021-07-08 | Marengo Therapeutics, Inc. | Multifunctional molecules that bind to cd33 and uses thereof |
EP4126929A1 (en) | 2020-03-25 | 2023-02-08 | Eli Lilly and Company | Multispecific binding proteins and methods of developing the same |
JP2023523011A (ja) | 2020-04-24 | 2023-06-01 | マレンゴ・セラピューティクス,インコーポレーテッド | T細胞関連のがん細胞に結合する多機能性分子およびその使用 |
CN116249718A (zh) | 2020-08-26 | 2023-06-09 | 马伦戈治疗公司 | 结合至钙网蛋白的多功能性分子及其用途 |
GB2616128A (en) | 2020-08-26 | 2023-08-30 | Marengo Therapeutics Inc | Antibody molecules that bind to NKp30 and uses thereof |
CN116761818A (zh) | 2020-08-26 | 2023-09-15 | 马伦戈治疗公司 | 检测trbc1或trbc2的方法 |
BR112023020832A2 (pt) | 2021-04-08 | 2023-12-19 | Marengo Therapeutics Inc | Moléculas multifuncionais ligadas a tcr e seus usos |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020062010A1 (en) | 1997-05-02 | 2002-05-23 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
ES2528794T3 (es) * | 2000-04-11 | 2015-02-12 | Genentech, Inc. | Anticuerpos multivalentes y usos de los mismos |
EP1864998B2 (en) | 2004-07-22 | 2022-06-22 | Erasmus University Medical Center Rotterdam | Binding molecules |
JP2009541275A (ja) * | 2006-06-22 | 2009-11-26 | ノボ・ノルデイスク・エー/エス | 二重特異性抗体の生産 |
EP2143345A1 (en) * | 2008-07-09 | 2010-01-13 | Reemtsma Cigarettenfabriken GmbH | Cigarette paper |
AU2010265933B2 (en) | 2009-06-26 | 2015-05-14 | Regeneron Pharmaceuticals, Inc. | Readily isolated bispecific antibodies with native immunoglobulin format |
-
2013
- 2013-03-13 DK DK13739281.7T patent/DK2825559T3/da active
- 2013-03-13 US US13/798,485 patent/US9815909B2/en active Active
- 2013-03-13 WO PCT/IB2013/000902 patent/WO2013136186A2/en active Application Filing
- 2013-03-13 ES ES13739281T patent/ES2728301T3/es active Active
- 2013-03-13 CA CA2867020A patent/CA2867020C/en active Active
- 2013-03-13 PT PT13739281T patent/PT2825559T/pt unknown
- 2013-03-13 EP EP19159351.6A patent/EP3517548A1/en not_active Withdrawn
- 2013-03-13 AU AU2013234039A patent/AU2013234039B2/en active Active
- 2013-03-13 EP EP13739281.7A patent/EP2825559B1/en active Active
- 2013-03-13 JP JP2014561539A patent/JP6273219B2/ja active Active
-
2017
- 2017-11-13 US US15/811,126 patent/US10494446B2/en active Active
- 2017-12-22 AU AU2017279804A patent/AU2017279804B2/en active Active
-
2018
- 2018-01-05 JP JP2018000542A patent/JP2018083829A/ja active Pending
-
2019
- 2019-11-27 US US16/698,248 patent/US20200231707A1/en not_active Abandoned
-
2021
- 2021-02-26 JP JP2021029357A patent/JP2021091701A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2021091701A (ja) | 2021-06-17 |
CA2867020C (en) | 2022-11-15 |
AU2013234039B2 (en) | 2018-02-01 |
US10494446B2 (en) | 2019-12-03 |
WO2013136186A2 (en) | 2013-09-19 |
WO2013136186A3 (en) | 2014-01-23 |
US20140051833A1 (en) | 2014-02-20 |
JP2015510764A (ja) | 2015-04-13 |
CA2867020A1 (en) | 2013-09-19 |
AU2013234039A1 (en) | 2014-09-25 |
JP2018083829A (ja) | 2018-05-31 |
US20200231707A1 (en) | 2020-07-23 |
AU2017279804B2 (en) | 2020-03-12 |
EP3517548A1 (en) | 2019-07-31 |
US20180057611A1 (en) | 2018-03-01 |
DK2825559T3 (da) | 2019-06-03 |
ES2728301T3 (es) | 2019-10-23 |
EP2825559A2 (en) | 2015-01-21 |
EP2825559B1 (en) | 2019-02-27 |
JP6273219B2 (ja) | 2018-01-31 |
US9815909B2 (en) | 2017-11-14 |
AU2017279804A1 (en) | 2018-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT2825559T (pt) | Anticorpos biespecíficos prontamente isolados com formato de imunoglobulina nativo | |
HRP20181717T1 (hr) | Bispecifična igg protutijela kao aktivatori t stanice | |
HK1210620A1 (en) | Multi-specific monoclonal antibodies | |
IL258940B (en) | Anti–il–23p19 antibodies | |
HK1204627A1 (en) | Anti-fcrn antibodies fcrn | |
HK1210027A1 (en) | Anti-human b7-h4 antibodies and their uses b7-h4 | |
IL235397B (en) | Antibodies specific for cll-1 | |
HK1204571A1 (en) | Protease-regulated antibodies | |
HK1210192A1 (en) | Anti-siglec-15 antibodies siglec-15 | |
EP3083698A4 (en) | Monoclonal anti-tk1 antibodies | |
EP2844290A4 (en) | NOVEL ANTIBODIES | |
ZA201407272B (en) | Anti-baff-anti-il-17 bispecific antibodies | |
HK1210186A1 (en) | Anti-h7cr antibodies h7cr | |
EP3088519A4 (en) | Novel anti-human bdca-2 antibody | |
HK1202454A1 (en) | Anti-p-selectin antibody formulation -p- | |
EP2804876A4 (en) | NEW ANTIBODIES | |
IL235188A0 (en) | Antibodies against c-pdgf |